test

 
Elevate your expertise in lipidology with Mastering Triglyceride Science: An In-Depth Master’s Course – a cutting-edge, master’s-level course series designed to bridge knowledge, competence, and practice gaps in hypertriglyceridemia management. This intensive, one-day program provides an unparalleled opportunity to deepen your understanding of severe hypertriglyceridemia, its complex pathophysiology, and the latest therapeutic strategies. Gain advanced proficiency in lipid science and enhance your ability to guide patients in making informed decisions about triglyceride-lowering therapies to mitigate the risk of life-threatening complications.

Why Attend?

  • Cutting-Edge Science: Stay ahead with the latest evidence-based research on triglyceride disorders, therapeutic targets, and emerging treatments.
  • Expert-Led Education: Learn from leading lipidologists and researchers at the forefront of triglyceride science.
  • Practical Application: Enhance your clinical acumen with real-world strategies to manage hypertriglyceridemia effectively.
  • Flexible Learning: Join us in person or virtually at our two premier NLA events in 2025.

When & Where?

  • NLA 2025 Scientific Sessions
    Date: Thursday, May 29, 2025
    Location: JW Marriott Miami Turnberry | Miami, FL
    REGISTER TO ATTEND IN-PERSON OR LIVE STREAM (Registration will open the first week of February)

  • NLA 2025 Fall Clinical Lipid Update
    Date: Friday, October 17, 2025
    Location: The Scottsdale Resort & Spa | Scottsdale, AZ
    REGISTER TO ATTEND IN-PERSON OR LIVE STREAM (Registration will open in mid-February) 

Who Should Attend?

This advanced course is tailored for lipid specialists looking to refine their expertise in triglyceride management, including:

  • Lipidologists & Preventive Cardiologists
  • Allied Health Lipid Specialists
  • Researchers & Clinicians Focused on Lipid Science
  • Healthcare Professionals with Advanced Knowledge in Lipidology

What You Will Gain

By participating in this master’s-level course, you will:

  • Strengthen your knowledge and competence in severe hypertriglyceridemia.
  • Explore the complexities of lipid science and cutting-edge research.
  • Develop a strategic approach to triglyceride-lowering therapies, including novel treatment options.
  • Enhance patient care with evidence-based solutions to reduce the risk of extreme complications from severe hypertriglyceridemia.

Join Us and Advance Your Expertise

Don’t miss this exclusive, high-level educational opportunity designed to refine your skills, deepen your knowledge, and position you as a leader in lipidology. Secure your spot today and take the next step in mastering triglyceride science!

At the conclusion of this activity, participants should be able to:

 
  • Describe the processes of triglyceride synthesis, secretion, and clearance.
  • Identify key pharmaceutical targets for treatment in relation to disease management.
  • Differentiate the clinical and genetic characteristics of Familial Chylomicronemia Syndrome (FCS), Multifactorial Chylomicronemia Syndrome (MCS), and Lipodystrophies.
  • Evaluate existing and emerging evidence-based treatment options for hypertriglyceridemia, with a focus on pancreatitis risk reduction.
  • Explain the mechanisms involved in hypertriglyceridemic pancreatitis and demonstrate the steps for accurate diagnosis and appropriate treatment.
  • Assess the impact of remnant lipoproteins on ASCVD risk and develop management strategies based on current evidence.
  • Identify dietary interventions tailored to specific triglyceride levels to optimize patient health and reduce cardiovascular or pancreatitis risk.
  • Enhance the healthcare team's approach by applying insights from interactive case discussions and best practice sharing.

 

Accreditation Information Coming Soon. 

Zahid Ahmad, MD, FNLA | Course Chair
Associate Professor of Internal Medicine
Lipid Section, Division of Endocrinology
UT Southwestern Medical Center
Dallas, TX
Elham Afghani, MD, MPH
Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Division of Gastroenterology and Hepatology
Baltimore, MD
Alan S. Brown, MD, MHA, MNLA
Director, Lipid Clinic
Advocate Lutheran General Hospital
Clinical Professor of Medicine
Rosalind Franklin School of Medicine and Science
Chicago, IL
Nivedita Patni, MD
Director, Pediatric Endocrinology Fellowship
Associate Professor of Pediatrics
Division of Pediatric Endocrinology
UT Southwestern Medical Center
Dallas, TX
Abhimanyu Garg, MD
Professor of Internal Medicine, Chief, Section of Nutrition and Metabolic Diseases, Division of Endocrinology
UT Southwestern Medical Center
Dallas, TX

The agenda will be updated throughout the planning process as new information and outcomes data is released.

Thursday, May 29, 2025

7:15 AM - 7:30 AM Welcome | Pre-test
7:30 AM - 8:00 AM Physiology and Disorders Associated with Triglyceride Synthesis and Secretion
8:00 AM - 8:05 AM BREAK
8:05 AM - 8:35 AM Lipolysis/Clearance, and Remnant Removal
8:35 AM - 8:50 AM Question & Answer
8:50 AM - 9:10 AM MCS
9:10 AM - 9:30 AM FCS
9:30 AM - 9:45 AM Question & Answer
9:45 AM - 10:00 AM BREAK
10:00 AM - 10:25 AM Lipodystrophies
10:25 AM - 10:40 AM Question & Answer
10:40 AM - 11:30 AM Mechanism, Diagnosis, and Treatment of Hypertriglyceridemic Pancreatitis
11:30 AM - 11:45 AM Question & Answer
11:45 AM - 12:30 PM LUNCH
12:30 PM - 1:00 PM Abstract Presentations
1:00 PM - 1:30 PM Mechanism, Diagnosis, and Treatment of Increased ASCVD Risk from Remnant Lipoproteins
1:30 PM - 1:45 PM Question & Answer
1:45 PM - 2:15 PM Current and Future Pharmacologic Treatments for Hypertriglyceridemia
2:15 PM - 2:30 PM Question & Answer
2:30 PM - 2:45 PM BREAK
2:45 PM - 3:40 PM Interactive Patient Cases | Roundtable Discussion | Tips & Tricks
3:40 PM - 4:00 PM Post-Test